Combination of Gemcitabine and Doxorubicin in Rapidly Progressive Metastatic Renal Cell Carcinoma and/or Sarcomatoid Renal Cell Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|80|3-4|214-218

ISSN： 0030-2414

Source： Oncology, Vol.80, Iss.3-4, 2011-07, pp. : 214-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor‐risk metastatic renal cell carcinoma

By  

CANCER, Vol. 121, Iss. 19, 2015-10 ,pp. : 3435-3443

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early-Stage Sarcomatoid Renal Cell Carcinoma: Multidetector CT Findings

By  

Urologia Internationalis, Vol. 82, Iss. 3, 2009-05 ,pp. : 367-369

Karger

Access to resources Recommend Favorite

Prognostic model for patients with sarcomatoid RCC

By  

BJU INTERNATIONAL, Vol. 115, Iss. 3, 2015-03 ,pp. : 405-411

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ramucirumab in metastatic renal cell carcinoma: The beginning or the end?

By  

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1604-1607

John Wiley & Sons Inc

Access to resources Recommend Favorite

Urologic Approaches to Metastatic Renal Cell Carcinoma

By  

Oncology Research and Treatment, Vol. 24, Iss. 2, 2001-05 ,pp. : 122-126

Karger

Access to resources Recommend Favorite